Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors

Nacide Ercan-Fang, Miriam R. Taylor, Judith L. Treadway, Carolyn B. Levy, Paul E. Genereux, E. Michael Gibbs, Virginia L. Rath, Younggil Kwon, Mary C. Cannon, Frank Q. Nuttall

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Phosphorylase is regulated by a number of small-molecular-weight effectors that bind to three sites on the enzyme. Recently, a fourth site referred to as the indole-inhibitor site has been identified. Synthetic compounds bind to the site and inhibit activity. However, the effects of these compounds in the presence of other endogenous effectors are unknown. We have determined the effects of four indole derivative glycogen phosphorylase inhibitors (GPI) on recombinant human liver glycogen phosphorylase a activity. The GPIs tested were all potent inhibitors. However, the endogenous inhibitors (glucose, ADP, ATP, fructose 1-phosphate, glucose 6-phosphate, UDP-glucose) and the activator (AMP) markedly reduced the inhibitory effect of GPIs. Consistent with these in vitro findings, the IC50 for the inhibition of glycogenolysis in cells and the liver drug concentration associated with glucose-lowering activity in diabetic ob/ob mice in vivo were also significantly higher than those determined in in vitro enzyme assays. The inhibitory effect of indole-site effectors is modulated by endogenous small-molecular-weight effectors of phosphorylase a activity. However, at higher concentrations (10-30 μM), the GPI effect was dominant and resulted in inhibition of phosphorylase a activity irrespective of the presence or absence of the other modulators of the enzyme.

Original languageEnglish (US)
Pages (from-to)E366-E372
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume289
Issue number3 52-3
DOIs
StatePublished - Sep 1 2005

Keywords

  • Glucose

Fingerprint Dive into the research topics of 'Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors'. Together they form a unique fingerprint.

  • Cite this

    Ercan-Fang, N., Taylor, M. R., Treadway, J. L., Levy, C. B., Genereux, P. E., Gibbs, E. M., Rath, V. L., Kwon, Y., Cannon, M. C., & Nuttall, F. Q. (2005). Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors. American Journal of Physiology - Endocrinology and Metabolism, 289(3 52-3), E366-E372. https://doi.org/10.1152/ajpendo.00264.2004